Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 10
2004 7
2005 5
2006 2
2007 9
2008 12
2009 12
2010 14
2011 10
2012 10
2013 12
2014 26
2015 15
2016 19
2017 18
2018 30
2019 24
2020 22
2021 29
2022 46
2023 40
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Results by year

Filters applied: . Clear all
Page 1
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators. Schuster SJ, et al. N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501490 Clinical Trial.
CXCR4-targeted theranostics in oncology.
Buck AK, Serfling SE, Lindner T, Hänscheid H, Schirbel A, Hahner S, Fassnacht M, Einsele H, Werner RA. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4133-4144. doi: 10.1007/s00259-022-05849-y. Epub 2022 Jun 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 35674738 Free PMC article. Review.
Theranostics in Hematooncology.
Buck AK, Serfling SE, Kraus S, Samnick S, Dreher N, Higuchi T, Rasche L, Einsele H, Werner RA. Buck AK, et al. J Nucl Med. 2023 Jul;64(7):1009-1016. doi: 10.2967/jnumed.122.265199. Epub 2023 Jun 8. J Nucl Med. 2023. PMID: 37290799 Free PMC article.
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: buck a. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Free article. Clinical Trial.
Adrenal functional imaging.
Werner RA, Schirbel A, Buck AK, Fassnacht M, Hahner S. Werner RA, et al. Among authors: buck ak. Presse Med. 2022 Jun;51(2):104114. doi: 10.1016/j.lpm.2022.104114. Epub 2022 Feb 4. Presse Med. 2022. PMID: 35131316
SPECT/CT.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Buck AK, et al. J Nucl Med. 2008 Aug;49(8):1305-19. doi: 10.2967/jnumed.107.050195. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632825 Free article.
Red Bull PET/CT.
Serfling SE, Buck A, Rowe SP, Higuchi T, Werner R. Serfling SE, et al. Among authors: buck a. Nuklearmedizin. 2024 Apr;63(2):76-77. doi: 10.1055/a-2195-0138. Epub 2023 Dec 22. Nuklearmedizin. 2024. PMID: 38134943 Free PMC article.
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.
Michalski K, Schlötelburg W, Hartrampf PE, Kosmala A, Buck AK, Hahner S, Schirbel A. Michalski K, et al. Among authors: buck ak. Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma.
Leipold AM, Werner RA, Düll J, Jung P, John M, Stanojkovska E, Zhou X, Hornburger H, Ruckdeschel A, Dietrich O, Imdahl F, Krammer T, Knop S, Rosenwald A, Buck A, Sander LE, Einsele H, Kortüm KM, Saliba AE, Rasche L. Leipold AM, et al. Among authors: buck a. Leukemia. 2023 Mar;37(3):650-658. doi: 10.1038/s41375-023-01824-0. Epub 2023 Jan 31. Leukemia. 2023. PMID: 36720972 Free PMC article.
CXCR4-directed theranostics in oncology and inflammation.
Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C. Kircher M, et al. Among authors: buck ak. Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Ann Nucl Med. 2018. PMID: 30105558 Free PMC article. Review.
344 results